ORC Should I Buy
-
$
0.000
0.000(0.000%)
At close0.000(0.000%)Aft-market
ET
Loading...
Buy now (tactical). ORC is trading around 8.16 pre-market, right on the pivot (8.149) with a bullish moving-average stack and strongly positive, earnings-driven news flow (Q4 profitability and book value up). Options positioning is heavily call-skewed (very low put/call ratios), suggesting risk-on sentiment. The main pushback is Wall Street’s only listed view: a Neutral rating with a $7.50 target (below spot), which caps longer-term upside expectations. For an impatient buyer, the setup favors buying now for a near-term move toward 8.37–8.51 resistance rather than waiting for a “perfect” pullback.
Trend/price action: Bullish trend structure with SMA_5 > SMA_20 > SMA_200, indicating an established uptrend. Momentum: MACD histogram is positive (0.0258) but contracting—uptrend still intact, though upside momentum is cooling. RSI: RSI_6 at 66.2 is still in the neutral zone but getting closer to overbought; this supports strength but increases the odds of brief pullbacks. Key levels: Pivot 8.149 is immediate “line in the sand.” If it holds, upside targets are R1 8.37 then R2 8.507. Downside supports are S1 7.927 then S2 7.79. Pattern-based outlook (provided): Higher probability of a small dip next day (-0.88% with 60% chance), but positive bias over the next week/month (+10.36% / +13.44%).
Intellectia Proprietary Trading Signals
and net interest income 38.5M beat expectations.
remains below the trading price, so the stock is still at a premium to BV, which can limit upside if rates/spreads move against mortgage REITs.
Latest quarter season highlighted in news: 2025/Q4 showed a major profitability improvement (Q4 GAAP EPS 0.62) alongside stronger net interest income (38.5M) and sizable portfolio gains (70.7M). Book value per share improved to 7.54 at quarter-end, consistent with better shareholder returns. Most recent provided financial snapshot: 2025/Q3 showed sharp growth trends—Revenue 159.034M (+78.90% YoY), Net Income 72.078M (+316.15% YoY), EPS 0.53 (+120.83% YoY), and Gross Margin 48.74 (+100.66% YoY). Overall, the recent quarters indicate a strong rebound phase rather than flat/stagnant performance.
Recent analyst change: On 2025-12-15, Compass Point initiated coverage at Neutral with a $7.50 price target. Wall Street pros view (from provided data): Pros: The company is delivering materially better quarter results (notably Q4) with improving book value and maintaining dividends—supportive for income/total-return buyers. Cons: Neutral rating and sub-market price target suggest professionals see valuation/interest-rate sensitivity as a constraint, and the stock may be pricing in a lot of the improvement already. Influential/politician activity: No recent congress trading data available. Hedge fund and insider trend data are both Neutral with no significant recent activity.
